What Trump’s Latest Moves Mean for the Industry
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
False
May 27, 2025
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
6 min read
By Rob Coker
April 11, 2025
FDA to phase out mandatory animal testing with human-relevant methods for drug development
2 min read
By Elizabeth Hickman, Dave Miller
April 11, 2025
In the ever volatile, highly regulated precision medicine development sector, the agility and expertise of a CDMO can make or break a commercial drug candidate.
3 min read
By Stephanie Vine
April 9, 2025
US President threatens “major tariff” on pharmaceuticals.
2 min read
April 9, 2025
We dive into the archive of 2022 for insight and inspiration – this time with Kowid Ho
3 min read
By Stephanie Vine
April 9, 2025
Lore Gruenbaum tells us about her career spanning big pharma, biotech and now The Leukemia & Lymphoma Society; because there are some goals you can only accomplish in a not-for-profit environment.
7 min read
By Stephanie Vine
April 8, 2025
Job cuts at the FDA spark concern, with Robert Califf saying the agency as we know it is “finished.”
3 min read
April 8, 2025
We asked experts about their views of the future of pharma. Process digitization, data, and sustainability are key themes.
4 min read
By Stephanie Vine
April 4, 2025
We ask James Chambers from Tufts Medical Center about the challenges faced by biosimilars in the US
7 min read
April 4, 2025
We dive into the archive of 2021 for insight and inspiration – this time with Peter Marks
3 min read
False
False
False